Di Desidero, T., Xu, P., Man, S., Bocci, G., & Kerbel, R. S. (2015). Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer. Oncotarget.
Citação norma ChicagoDi Desidero, Teresa, Ping Xu, Shan Man, Guido Bocci, and Robert S. Kerbel. "Potent Efficacy of Metronomic Topotecan and Pazopanib Combination Therapy in Preclinical Models of Primary or Late Stage Metastatic Triple-negative Breast Cancer." Oncotarget 2015.
Citação norma MLADi Desidero, Teresa, et al. "Potent Efficacy of Metronomic Topotecan and Pazopanib Combination Therapy in Preclinical Models of Primary or Late Stage Metastatic Triple-negative Breast Cancer." Oncotarget 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.